(19)
(11) EP 1 047 779 A2

(12)

(88) Date of publication A3:
09.12.1999

(43) Date of publication:
02.11.2000 Bulletin 2000/44

(21) Application number: 99903179.2

(22) Date of filing: 19.01.1999
(51) International Patent Classification (IPC)7C12N 15/12, C07K 14/47, C12N 15/11, A61K 38/17, A61K 31/70, C12Q 1/68, G01N 33/68, A61K 48/00
(86) International application number:
PCT/US9901/087
(87) International publication number:
WO 9936/536 (22.07.1999 Gazette 1999/29)
(84) Designated Contracting States:
DE ES FR GB IT NL

(30) Priority: 20.01.1998 US 71950 P

(71) Applicant: BLOOD CENTER RESEARCH FOUNDATION
Milwaukee, WI 53233 (US)

(72) Inventors:
  • SIMS, Peter, J.
    Del Mar, CA 92014 (US)
  • WIEDMER, Therese
    Del Mar, CA 92014 (US)
  • ZHAO, Ji
    Solano, CA 92075 (US)

(74) Representative: Ellis-Jones, Patrick George Armine et al
J.A. KEMP & CO.14 South SquareGray's Inn
London WC1R 5LX
London WC1R 5LX (GB)

   


(54) METHODS AND COMPOSITIONS TO ALTER TISSUE SUSCEPTIBILITY TO IMMUNE INJURY, TO PROGRAMMED CELL DEATH, AND TO CLEARANCE BY THE RETICULOENDOTHELIAL SYSTEM